Vilvet Pharmaceuticals Inc. recalls VILEVEV MB Urinary Antispetic (81.0 mg methenamine, 40.8 mg sodium phosphate monobasic and 10.8 mg methylene blue, 0.12
Vilvet Pharmaceuticals recalls VILEVEV MB Urinary Antispetic due to cGMP deviations. This medication, sold in 90-tablet bottles with specific lot numbers, may have quality issues affecting safety.
Recall notice
cGMP deviations
Contact the company & request your remedy
What happened, in plain English
Vilvet Pharmaceuticals is recalling VILEVEV MB Urinary Antispetic tablets because of manufacturing quality issues. This recall affects people who have the specific lot numbers listed and may pose a risk to safety. Read more at govinfonow.com/recall/36910-vilvet-vilevev-mb-urinary-antispetic-recall-cgmp-deviations.
Source Summary by GovInfoNow · govinfonow.com/recall/36910-vilvet-vilevev-mb-urinary-antispetic-recall-cgmp-deviations · Updated October 5, 2026 · FDA enforcement record: FDA #D-1488-2020
Cite this page
“Vilvet VILEVEV MB Urinary Antispetic Recall: Cgmp Deviations.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/36910-vilvet-vilevev-mb-urinary-antispetic-recall-cgmp-deviations. Based on FDA recall #D-1488-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1488-2020%22&limit=1).
Why it’s dangerous
The recall is due to cGMP deviations, which are manufacturing quality issues that may affect the safety and effectiveness of the medication. These deviations could lead to potential risks if the medication is not properly controlled during production.
Who’s affected
People who have the VILEVEV MB Urinary Antispetic medication with lot numbers M823J18-1, M823J18-2, M823J18-3 (expiring 09/20) or M823D19-1 (expiring 04/21) are affected. Those who have this medication for medical use are most at risk.
How to tell if you have this one
Check the product label for the lot numbers M823J18-1, M823J18-2, M823J18-3 (expiring 09/20) or M823D19-1 (expiring 04/21). The medication is a prescription-only product with 90 tablets per bottle.
- Brand
Vilvet Pharmaceuticals- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide within the US
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1487-2020 | VILAMIT MB (118 mg methenamine, 36 mg phenyl salicylate, 40.8 mg sodium phosphate monobasic, 10.0 mg methylene blue and 0.12 mg hyoscyamine sulfate), Rx Only, 100 Capsules per Bottle, Manufactured for: Vilvet Pharmaceuticals Inc., Chester Springs, PA 18425, NDC 71186-002-35.; LOT M824H18-1 EXP 08/20 LOT M824J18-1 EXP 09/20 LOT M824L18-1 EXP 11/20 LOT M824A19-1 EXP 01/21 LOT M824C19-1 EXP 03/21 LOT M824G19-1 EXP 07/21 | 11,640 bottles |
| D-1488-2020 | VILEVEV MB Urinary Antispetic (81.0 mg methenamine, 40.8 mg sodium phosphate monobasic and 10.8 mg methylene blue, 0.12 mg hyoscyamine sulfate and 32.4 mg phenyl salicylate), Rx Only, 90 Tablets per Bottle, Manufactured for: Vilvet Pharmaceuticals, Inc., Chester Springs, PA 19425, NDC 71186-000-24.; LOT M823J18-1, M823J18-2, M823J18-3 EXP 09/20; LOT M823D19-1 EXP 04/21 | 1,716 bottles |
What to do — step by step
Check Product Label
Look for the lot numbers M823J18-1, M823J18-2, M823J18-3 (expiring 09/20) or M823D19-1 (expiring 04/21) on the medication bottle.
Questions people ask
Is this medication safe to use?
The recall is due to cGMP deviations, which may affect safety. The manufacturer has not provided specific details on the risk level, so it is recommended to check the lot numbers and follow the recall instructions.
How can I tell if I have the recalled product?
Check the product label for lot numbers M823J18-1, M823J18-2, M823J18-3 (expiring 09/20) or M823D19-1 (expiring 04/21). The medication is a prescription-only product with 90 tablets per bottle.
What should I do if I have the recalled product?
The recall does not specify a remedy, so you should check the product label and contact Vilvet Pharmaceuticals for further instructions.
Contact Vilvet Pharmaceuticals
We’ve drafted a message you can send Vilvet Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-1488-2020 — Vilvet Pharmaceuticals Vilvet Pharmaceuticals Hello, I own a Vilvet Pharmaceuticals that is covered by recall D-1488-2020 from Vilvet Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1488-2020 (July 24, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1488-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.